Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
| Cat.No. | Product Name | Price |
|---|---|---|
| CSC-DC004659 | Panoply™ Human DYX1C1 Knockdown Stable Cell Line | Inquiry |
| CSC-SC004659 | Panoply™ Human DYX1C1 Over-expressing Stable Cell Line | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| AD05207Z | Human DYX1C1 adenoviral particles | Inquiry |
| LV11334L | human DYX1C1 (NM_130810) lentivirus particles | Inquiry |
| LV11335L | human DYX1C1 (NM_001033560) lentivirus particles | Inquiry |
| LV11336L | human DYX1C1 (NM_001033559) lentivirus particles | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| SHH021143 | shRNA set against Rat Dyx1c1(NM_001007010.1) | Inquiry |
| SHH021215 | shRNA set against Human DYX1C1(NM_001033560.1) | Inquiry |
| SHW000801 | shRNA set against Chicken DYX1C1 (NM_001008674) | Inquiry |
| SHW017597 | shRNA set against Danio rerio DYX1C1 (NM_205688) | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| CDFG020491 | Mouse Dyx1c1 cDNA Clone(NM_001163725.1) | Inquiry |
| CDFH005571 | Human DYX1C1 cDNA Clone(NM_001033560.1) | Inquiry |
| CDFR001586 | Rat Dyx1c1 cDNA Clone(NM_001007010.1) | Inquiry |
| MiUTR1H-03072 | DYX1C1 miRNA 3'UTR clone | Inquiry |
| MiUTR1R-01627 | DYX1C1 miRNA 3'UTR clone | Inquiry |
| MiUTR3H-10160 | DYX1C1 miRNA 3'UTR clone | Inquiry |
| MiUTR3H-10162 | DYX1C1 miRNA 3'UTR clone | Inquiry |
| CDCB162276 | Chicken DYX1C1 ORF Clone (NM_001008674) | Inquiry |
| CDCB179072 | Danio rerio DYX1C1 ORF Clone (NM_205688) | Inquiry |
| CDCB187871 | Rabbit DYX1C1 ORF clone (XM_002717733.2) | Inquiry |
| CDCR058066 | Human DYX1C1 ORF clone (NM_001033560.1) | Inquiry |
| CDCR058072 | Mouse Dyx1c1 ORF clone (NM_001163725.1) | Inquiry |
| CDCR257993 | Mouse Dyx1c1 ORF Clone(NM_026314.3) | Inquiry |
| CDCR368477 | Rat Dyx1c1 ORF Clone(NM_001007010.1) | Inquiry |
| CDCS406837 | Human DYX1C1 ORF Clone (BC062564) | Inquiry |